Alexander Nikitin - Publications

Cornell University, Ithaca, NY, United States 
Veterinary Science Biology, Biomedical Engineering

54 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Rose IM, Bidarimath M, Webster A, Godwin AK, Flesken-Nikitin A, Nikitin AY. WNT and inflammatory signaling distinguish human Fallopian tube epithelial cell populations. Scientific Reports. 10: 9837. PMID 32555344 DOI: 10.1038/s41598-020-66556-y  0.44
2020 Cheng CY, Zhou Z, Stone M, Lu B, Flesken-Nikitin A, Nanus DM, Nikitin AY. Membrane metalloendopeptidase suppresses prostate carcinogenesis by attenuating effects of gastrin-releasing peptide on stem/progenitor cells. Oncogenesis. 9: 38. PMID 32205838 DOI: 10.1038/s41389-020-0222-3  0.44
2020 Fu DJ, Wang L, Chouairi FK, Rose IM, Abetov DA, Miller AD, Yamulla RJ, Schimenti JC, Flesken-Nikitin A, Nikitin AY. Gastric squamous-columnar junction contains a large pool of cancer-prone immature osteopontin responsive Lgr5CD44 cells. Nature Communications. 11: 84. PMID 31901081 DOI: 10.1038/s41467-019-13847-2  0.44
2017 Fu DJ, Miller AD, Southard TL, Flesken-Nikitin A, Ellenson LH, Nikitin AY. Stem Cell Pathology. Annual Review of Pathology. PMID 29059010 DOI: 10.1146/annurev-pathol-020117-043935  0.44
2017 Schmoeckel E, Odai-Afotey AA, Schleißheimer M, Rottmann M, Flesken-Nikitin A, Ellenson LH, Kirchner T, Mayr D, Nikitin AY. LEF1 is preferentially expressed in the tubal-peritoneal junctions and is a reliable marker of tubal intraepithelial lesions. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 28664938 DOI: 10.1038/modpathol.2017.53  0.44
2016 Flesken-Nikitin A, Harlan BA, Nikitin AY. Transplantation Into the Mouse Ovarian Fat Pad. Journal of Visualized Experiments : Jove. PMID 27684746 DOI: 10.3791/54444  0.44
2014 Flesken-Nikitin A, Odai-Afotey AA, Nikitin AY. Role of the stem cell niche in the pathogenesis of epithelial ovarian cancers. Molecular & Cellular Oncology. 1: e963435. PMID 27308341 DOI: 10.4161/23723548.2014.963435  0.44
2014 Chinnam M, Wang Y, Zhang X, Gold DL, Khoury T, Nikitin AY, Foster BA, Li Y, Bshara W, Morrison CD, Payne Ondracek RD, Mohler JL, Goodrich DW. The Thoc1 ribonucleoprotein and prostate cancer progression. Journal of the National Cancer Institute. 106. PMID 25296641 DOI: 10.1093/jnci/dju306  0.32
2014 Cheng CY, Hwang CI, Corney DC, Flesken-Nikitin A, Jiang L, Oner GM, Munroe RJ, Schimenti JC, Hermeking H, Nikitin AY. miR-34 cooperates with p53 in suppression of prostate cancer by joint regulation of stem cell compartment. Cell Reports. 6: 1000-7. PMID 24630988 DOI: 10.1016/j.celrep.2014.02.023  0.48
2014 Sui H, Zhu HR, Wu J, Nikitin AY, Cai JF, Fan ZZ, Li Q. Effects of Jianpi Jiedu Recipeon reversion of P-glycoprotein-mediated multidrug resistance through COX-2 pathway in colorectal cancer Chinese Journal of Integrative Medicine. 20: 610-617. PMID 23543356 DOI: 10.1007/s11655-013-1452-4  0.32
2013 Adisetiyo H, Liang M, Liao CP, Aycock-Williams A, Cohen MB, Xu S, Neamati N, Conway EM, Cheng CY, Nikitin AY, Roy-Burman P. Loss of survivin in the prostate epithelium impedes carcinogenesis in a mouse model of prostate adenocarcinoma. Plos One. 8: e69484. PMID 23936028 DOI: 10.1371/journal.pone.0069484  0.32
2013 Flesken-Nikitin A, Hwang CI, Cheng CY, Michurina TV, Enikolopov G, Nikitin AY. Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche. Nature. 495: 241-5. PMID 23467088 DOI: 10.1038/nature11979  0.32
2012 Jesty SA, Steffey MA, Lee FK, Breitbach M, Hesse M, Reining S, Lee JC, Doran RM, Nikitin AY, Fleischmann BK, Kotlikoff MI. c-kit+ precursors support postinfarction myogenesis in the neonatal, but not adult, heart. Proceedings of the National Academy of Sciences of the United States of America. 109: 13380-5. PMID 22847442 DOI: 10.1073/pnas.1208114109  0.32
2012 Chandler EM, Seo BR, Califano JP, Andresen Eguiluz RC, Lee JS, Yoon CJ, Tims DT, Wang JX, Cheng L, Mohanan S, Buckley MR, Cohen I, Nikitin AY, Williams RM, Gourdon D, et al. Implanted adipose progenitor cells as physicochemical regulators of breast cancer. Proceedings of the National Academy of Sciences of the United States of America. 109: 9786-91. PMID 22665775 DOI: 10.1073/pnas.1121160109  0.32
2012 Sundberg JP, Hogenesch H, Nikitin AY, Treuting PM, Ward JM. Training mouse pathologists: ten years of workshops on the Pathology of Mouse Models of Human Disease. Toxicologic Pathology. 40: 823-5. PMID 22421749 DOI: 10.1177/0192623312439123  0.32
2012 Gu X, Vedvyas Y, Chen X, Kaushik T, Hwang CI, Hu X, Nikitin AY, Jin MM. Novel strategy for selection of monoclonal antibodies against highly conserved antigens: phage library panning against ephrin-B2 displayed on yeast. Plos One. 7: e30680. PMID 22292016 DOI: 10.1371/journal.pone.0030680  0.32
2012 Migone FF, Ren Y, Cowan RG, Harman RM, Nikitin AY, Quirk SM. Dominant activation of the hedgehog signaling pathway alters development of the female reproductive tract. Genesis (New York, N.Y. : 2000). 50: 28-40. PMID 21809434 DOI: 10.1002/dvg.20786  0.32
2011 Hwang CI, Choi J, Zhou Z, Flesken-Nikitin A, Tarakhovsky A, Nikitin AY. MET-dependent cancer invasion may be preprogrammed by early alterations of p53-regulated feedforward loop and triggered by stromal cell-derived HGF. Cell Cycle (Georgetown, Tex.). 10: 3834-40. PMID 22071625 DOI: 10.4161/cc.10.22.18294  0.44
2011 Hwang CI, Matoso A, Corney DC, Flesken-Nikitin A, Körner S, Wang W, Boccaccio C, Thorgeirsson SS, Comoglio PM, Hermeking H, Nikitin AY. Wild-type p53 controls cell motility and invasion by dual regulation of MET expression. Proceedings of the National Academy of Sciences of the United States of America. 108: 14240-5. PMID 21831840 DOI: 10.1073/pnas.1017536108  0.48
2011 Bolon B, Altrock B, Barthold SW, Baumgarth N, Besselsen D, Boivin G, Boyd KL, Brayton C, Cardiff RD, Couto S, Eaton KA, Foreman O, Griffey SM, La Perle K, Lairmore MD, ... ... Nikitin AY, et al. Advancing translational research. Science (New York, N.Y.). 331: 1516-7. PMID 21436422 DOI: 10.1126/science.331.6024.1516-b  0.32
2011 Sun H, Wang Y, Chinnam M, Zhang X, Hayward SW, Foster BA, Nikitin AY, Wills M, Goodrich DW. E2f binding-deficient Rb1 protein suppresses prostate tumor progression in vivo. Proceedings of the National Academy of Sciences of the United States of America. 108: 704-9. PMID 21187395 DOI: 10.1073/pnas.1015027108  0.32
2010 Choi J, Curtis SJ, Roy DM, Flesken-Nikitin A, Nikitin AY. Local mesenchymal stem/progenitor cells are a preferential target for initiation of adult soft tissue sarcomas associated with p53 and Rb deficiency. The American Journal of Pathology. 177: 2645-58. PMID 20864684 DOI: 10.2353/ajpath.2010.100306  0.44
2010 Cheng L, Zhou Z, Flesken-Nikitin A, Toshkov IA, Wang W, Camps J, Ried T, Nikitin AY. Rb inactivation accelerates neoplastic growth and substitutes for recurrent amplification of cIAP1, cIAP2 and Yap1 in sporadic mammary carcinoma associated with p53 deficiency. Oncogene. 29: 5700-11. PMID 20676140 DOI: 10.1038/onc.2010.300  0.32
2010 Liao CP, Liang M, Cohen MB, Flesken-Nikitin A, Jeong JH, Nikitin AY, Roy-Burman P. Mouse prostate cancer cell lines established from primary and postcastration recurrent tumors. Hormones & Cancer. 1: 44-54. PMID 20631921 DOI: 10.1007/s12672-009-0005-y  0.32
2010 Liu K, Cheng L, Flesken-Nikitin A, Huang L, Nikitin AY, Pauli BU. Conditional knockout of fibronectin abrogates mouse mammary gland lobuloalveolar differentiation. Developmental Biology. 346: 11-24. PMID 20624380 DOI: 10.1016/j.ydbio.2010.07.001  0.32
2010 Williams RM, Flesken-Nikitin A, Ellenson LH, Connolly DC, Hamilton TC, Nikitin AY, Zipfel WR. Strategies for high-resolution imaging of epithelial ovarian cancer by laparoscopic nonlinear microscopy. Translational Oncology. 3: 181-94. PMID 20563260  0.44
2010 Corney DC, Hwang CI, Matoso A, Vogt M, Flesken-Nikitin A, Godwin AK, Kamat AA, Sood AK, Ellenson LH, Hermeking H, Nikitin AY. Frequent downregulation of miR-34 family in human ovarian cancers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 1119-28. PMID 20145172 DOI: 10.1158/1078-0432.CCR-09-2642  0.32
2010 Li B, Antonyak MA, Druso JE, Cheng L, Nikitin AY, Cerione RA. EGF potentiated oncogenesis requires a tissue transglutaminase-dependent signaling pathway leading to Src activation. Proceedings of the National Academy of Sciences of the United States of America. 107: 1408-13. PMID 20080707 DOI: 10.1073/pnas.0907907107  0.32
2010 Cheng L, Ramesh AV, Flesken-Nikitin A, Choi J, Nikitin AY. Mouse models for cancer stem cell research. Toxicologic Pathology. 38: 62-71. PMID 19920280 DOI: 10.1177/0192623309354109  0.44
2008 Corney DC, Nikitin AY. MicroRNA and ovarian cancer. Histology and Histopathology. 23: 1161-9. PMID 18581287  0.48
2008 Corney DC, Flesken-Nikitin A, Choi J, Nikitin AY. Role of p53 and Rb in ovarian cancer. Advances in Experimental Medicine and Biology. 622: 99-117. PMID 18546622 DOI: 10.1007/978-0-387-68969-2_9  0.48
2008 Schug TT, Berry DC, Toshkov IA, Cheng L, Nikitin AY, Noy N. Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARbeta/delta to RAR. Proceedings of the National Academy of Sciences of the United States of America. 105: 7546-51. PMID 18495924 DOI: 10.1073/pnas.0709981105  0.32
2008 Antoch MP, Gorbacheva VY, Vykhovanets O, Toshkov IA, Kondratov RV, Kondratova AA, Lee C, Nikitin AY. Disruption of the circadian clock due to the Clock mutation has discrete effects on aging and carcinogenesis. Cell Cycle (Georgetown, Tex.). 7: 1197-204. PMID 18418054  0.32
2008 Xu X, Page JL, Surtees JA, Liu H, Lagedrost S, Lu Y, Bronson R, Alani E, Nikitin AY, Weiss RS. Broad overexpression of ribonucleotide reductase genes in mice specifically induces lung neoplasms. Cancer Research. 68: 2652-60. PMID 18413732 DOI: 10.1158/0008-5472.CAN-07-5873  0.32
2008 Matoso A, Zhou Z, Hayama R, Flesken-Nikitin A, Nikitin AY. Cell lineage-specific interactions between Men1 and Rb in neuroendocrine neoplasia. Carcinogenesis. 29: 620-8. PMID 17893233 DOI: 10.1093/carcin/bgm207  0.32
2007 Choi J, Burns AA, Williams RM, Zhou Z, Flesken-Nikitin A, Zipfel WR, Wiesner U, Nikitin AY. Core-shell silica nanoparticles as fluorescent labels for nanomedicine. Journal of Biomedical Optics. 12: 064007. PMID 18163823 DOI: 10.1117/1.2823149  0.44
2007 Flesken-Nikitin A, Toshkov I, Naskar J, Tyner KM, Williams RM, Zipfel WR, Giannelis EP, Nikitin AY. Toxicity and biomedical imaging of layered nanohybrids in the mouse. Toxicologic Pathology. 35: 806-12. PMID 17943654 DOI: 10.1080/01926230701584239  0.32
2007 Corney DC, Flesken-Nikitin A, Godwin AK, Wang W, Nikitin AY. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Research. 67: 8433-8. PMID 17823410 DOI: 10.1158/0008-5472.CAN-07-1585  0.32
2007 Liao CP, Zhong C, Saribekyan G, Bading J, Park R, Conti PS, Moats R, Berns A, Shi W, Zhou Z, Nikitin AY, Roy-Burman P. Mouse models of prostate adenocarcinoma with the capacity to monitor spontaneous carcinogenesis by bioluminescence or fluorescence. Cancer Research. 67: 7525-33. PMID 17671224 DOI: 10.1158/0008-5472.CAN-07-0668  0.32
2007 Zhou Z, Flesken-Nikitin A, Nikitin AY. Prostate cancer associated with p53 and Rb deficiency arises from the stem/progenitor cell-enriched proximal region of prostatic ducts. Cancer Research. 67: 5683-90. PMID 17553900 DOI: 10.1158/0008-5472.CAN-07-0768  0.44
2007 Sundberg JP, Hackman RC, HogenEsch H, Nikitin AY, Ward JM. Training mouse pathologists: five years of pathology of mouse models of human disease workshops. Toxicologic Pathology. 35: 447-8. PMID 17474065 DOI: 10.1080/01926230701302566  0.32
2006 Zhou Z, Flesken-Nikitin A, Corney DC, Wang W, Goodrich DW, Roy-Burman P, Nikitin AY. Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer. Cancer Research. 66: 7889-98. PMID 16912162 DOI: 10.1158/0008-5472.CAN-06-0486  0.32
2006 Yuryev A, Mulyukov Z, Kotelnikova E, Maslov S, Egorov S, Nikitin A, Daraselia N, Mazo I. Automatic pathway building in biological association networks. Bmc Bioinformatics. 7: 171. PMID 16563163 DOI: 10.1186/1471-2105-7-171  0.32
2005 Zhou Z, Flesken-Nikitin A, Levine CG, Shmidt EN, Eng JP, Nikitina EY, Spencer DM, Nikitin AY. Suppression of melanotroph carcinogenesis leads to accelerated progression of pituitary anterior lobe tumors and medullary thyroid carcinomas in Rb+/- mice. Cancer Research. 65: 787-96. PMID 15705875  0.32
2005 Flesken-Nikitin A, Williams RM, Zipfel WR, Webb WW, Nikitin AY. Use of multiphoton imaging for studying cell migration in the mouse. Methods in Molecular Biology (Clifton, N.J.). 294: 335-45. PMID 15576922  0.44
2004 Nikitin AY, Connolly DC, Hamilton TC. Pathology of Ovarian Neoplasms in Genetically Modified Mice. Comparative Medicine. 54: 26-8. PMID 15382342  0.32
2004 Lin SC, Lee KF, Nikitin AY, Hilsenbeck SG, Cardiff RD, Li A, Kang KW, Frank SA, Lee WH, Lee EY. Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis. Cancer Research. 64: 3525-32. PMID 15150107 DOI: 10.1158/0008-5472.CAN-03-3524  0.32
2004 Nikitin AY, Alcaraz A, Anver MR, Bronson RT, Cardiff RD, Dixon D, Fraire AE, Gabrielson EW, Gunning WT, Haines DC, Kaufman MH, Linnoila RI, Maronpot RR, Rabson AS, Reddick RL, et al. Classification of proliferative pulmonary lesions of the mouse: recommendations of the mouse models of human cancers consortium. Cancer Research. 64: 2307-16. PMID 15059877 DOI: 10.1158/0008-5472.CAN-03-3376  0.32
2003 Manor D, Shmidt EN, Budhu A, Flesken-Nikitin A, Zgola M, Page R, Nikitin AY, Noy N. Mammary carcinoma suppression by cellular retinoic acid binding protein-II. Cancer Research. 63: 4426-33. PMID 12907615  0.32
2003 Flesken-Nikitin A, Choi KC, Eng JP, Shmidt EN, Nikitin AY. Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium. Cancer Research. 63: 3459-63. PMID 12839925  0.44
2003 Connolly DC, Bao R, Nikitin AY, Stephens KC, Poole TW, Hua X, Harris SS, Vanderhyden BC, Hamilton TC. Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer. Cancer Research. 63: 1389-97. PMID 12649204  0.32
2003 Sharp ZD, Lee WH, Nikitin AY, Flesken-Nikitin A, Ikeno Y, Reddick R, Richardson AG, Nelson JF. Minimal effects of dietary restriction on neuroendocrine carcinogenesis in Rb+/- mice. Carcinogenesis. 24: 179-83. PMID 12584165 DOI: 10.1093/carcin/24.2.179  0.32
2002 Tsai KY, MacPherson D, Rubinson DA, Nikitin AY, Bronson R, Mercer KL, Crowley D, Jacks T. ARF mutation accelerates pituitary tumor development in Rb+/- mice. Proceedings of the National Academy of Sciences of the United States of America. 99: 16865-70. PMID 12486224 DOI: 10.1073/pnas.262499599  0.32
2002 Nikitin AY, Liu CY, Flesken-Nikitin A, Chen CF, Chen PL, Lee WH. Cell lineage-specific effects associated with multiple deficiencies of tumor susceptibility genes in Msh2(-/-)Rb(+/-) mice. Cancer Research. 62: 5134-8. PMID 12234974  0.44
Show low-probability matches.